HCLTech Shares Rally After Q2 Results: Stock Outlook and Key Factors to Watch
HCLTech shares rallied on October 13, 2026, after the IT major reported a 21.2% year-on-year rise in net profit for […]
Nifty 50 Trails Asian Peers: What Is Holding Back Indian Equities?
The Nifty 50 trailing other Asian stock markets can reflect a combination of valuation concerns, foreign investor outflows, corporate earnings
Lenskart Shares Fall Over 4% Amid Buzz of ₹1,691 Crore Block Deal
Lenskart shares fell more than 4% amid reports of a potential ₹1,691 crore block deal, putting the eyewear retailer in
DMart Shares Fall 4% After Q2 Results: Is This a Buying Opportunity?
DMart shares fell around 4% following the company’s second quarter results, prompting investors to reassess its growth prospects, profit margins
Steel Stocks Rise Up to 2%: SAIL, APL Apollo, Jindal Steel Lead Gains. Here’s Why
Steel stocks in India gained up to 2% as investors assessed demand prospects, steel price trends and expectations for infrastructure
USD vs INR: Rupee Jumps 97 Paise After RBI’s Dollar Move. Is This a Temporary Relief Rally?
The Indian rupee strengthened by 97 paise to ₹95.76 against the US dollar at the opening of trading on October
AMFI September Data 2026: Mutual Fund AUM Falls 5.1% to ₹82.64 Lakh Crore, SIP Inflows Hit Record ₹32,490 Crore
India’s mutual fund industry reported mixed trends in September 2026, with total assets under management (AUM) falling 5.1% month on
Crude Oil Prices Today: Brent Falls Below $104, WTI Near $91 as Trump Rules Out Iran Attack Before US Polls
Crude oil prices declined on October 9, 2026, after US President Donald Trump said the United States would not attack
Bulls Return to Dalal Street: Sensex Gains Over 300 Points, Nifty Above 22,300
Indian stock markets rebounded on October 9, 2026, as the BSE Sensex gained more than 300 points and the Nifty
30% Margin Cap on Cancer Drugs: Why Analysts Expect a Limited Hit to Hospital Earnings
India’s proposed 30% margin cap on cancer drugs could reduce the amount hospitals earn from selling certain medicines, but analysts